NON-CYSTIC FIBROSIS BRONCHIECTASIS
Clinical trials for NON-CYSTIC FIBROSIS BRONCHIECTASIS explained in plain language.
Never miss a new study
Get alerted when new NON-CYSTIC FIBROSIS BRONCHIECTASIS trials appear
Sign up with your email to follow new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a CF drug help people with a different lung disease?
Disease control CompletedThis study tested whether Trikafta, a drug already approved for cystic fibrosis, can help people with non-cystic fibrosis bronchiectasis (NCFBE). Thirty-two adults took the medication for 28 days. Researchers measured lung function, quality of life, and weight, and also looked at…
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Phase: PHASE4 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Virus cocktail inhaled to fight Drug-Resistant lung infection
Disease control CompletedThis study tested an inhaled mixture of bacteria-killing viruses (phages) in 48 adults with bronchiectasis and chronic Pseudomonas lung infections. Participants received either the phage therapy or a placebo by inhalation. The goal was to see if the phages could safely reduce the…
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Phase: PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New pill could cut dangerous lung Flare-Ups in bronchiectasis patients
Disease control CompletedThis large Phase 3 trial tested whether a daily pill called brensocatib can reduce the number of lung infections (called pulmonary exacerbations) in people with non-CF bronchiectasis, a chronic lung condition. Over 1,700 adults and adolescents took either 10 mg, 25 mg of brensoca…
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC